Footnotes
This manuscript has recently been accepted for publication in theEuropean Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of theERJonline. Please open or download the PDF to view this article.
Conflict of interest: Dr. Sitbon reports personal fees and non-financial support from Actelion Pharmaceuticals Ltd, during the conduct of the study; grants, personal fees and non-financial support from Actelion Pharmaceuticals, grants and personal fees from Bayer HealthCare, grants, personal fees and non-financial support from GlaxoSmithKline, grants and personal fees from Merck, personal fees and other from Arena Pharmaceuticals, personal fees from Gossamer Bio, personal fees from Ferrer, outside the submitted work.
Conflict of interest: Dr. Cottin reports non-financial support from Actelion Pharmaceuticals Ltd, personal fees from Actelion Pharmaceuticals France Ltd, during the conduct of the study; personal fees and non-financial support from Actelion, grants, personal fees and non-financial support from Boehringer Ingelheim, personal fees from Bayer/MSD, personal fees from Gilead, personal fees from Novartis, grants, personal fees and non-financial support from Roche, personal fees from Sanofi, personal fees from Promedior, personal fees from Celgene, personal fees from Galapagos, personal fees from Galecto, outside the submitted work.
Conflict of interest: Dr. Canuet reports non-financial support from Actelion Pharmaceuticals Ltd., personal fees from Actelion Pharmaceuticals France Ltd, during the conduct of the study; personal fees from Actelion Pharmaceuticals Ltd, outside the submitted work.
Conflict of interest: Dr. Clerson reports personal fees and non-financial support from Actelion Pharmaceuticals Ltd., during the conduct of the study.
Conflict of interest: Dr. Gressin reports personal fees and non-financial support from Actelion Pharmaceuticals Ltd., personal fees from Actelion Pharmaceuticals France, during the conduct of the study; personal fees and other from Actelion Pharmaceuticals Ltd., other from Idorsia Pharmaceuticals Ltd, personal fees and other from Actelion Pharmaceuticals France, outside the submitted work.
Conflict of interest: Dr. Perchenet reports personal fees and non-financial support from Actelion Pharmaceuticals Ltd., during the conduct of the study; personal fees from Actelion Pharmaceuticals Ltd., outside the submitted work.
Conflict of interest: Dr. Bertoletti reports non-financial support from Actelion Pharmaceuticals Ltd., during the conduct of the study; non-financial support from Actelion Pharmaceuticals Ltd., personal fees and non-financial support from Bayer, non-financial support from Pfizer, personal fees from Daichii-Sankyo, outside the submitted work.
利益冲突:Bouvaist博士在研究期间向Actelion Pharmaceuticals Ltd.的非财政支持报告了非财政支持。
Conflict of interest: Dr. Picard reports non-financial support from Actelion Pharmaceuticals Ltd., personal fees from Actelion Pharmaceuticals France Ltd, during the conduct of the study; personal fees and non-financial support from Novartis, outside the submitted work.
Conflict of interest: Dr. Prévot reports non-financial support from Actelion Pharmaceuticals Ltd., personal fees from Actelion Pharmaceuticals France Ltd, during the conduct of the study.
Conflict of interest: Dr. Bergot reports non-financial support from Actelion Pharmaceuticals Ltd., personal fees from Actelion Pharmaceuticals France Ltd, during the conduct of the study; personal fees and other from Chiesi Pharmaceuticals, personal fees from Actelion Pharmaceuticals Ltd., personal fees from Boehringer Ingelheim, personal fees from Roche, personal fees from Novartis, personal fees from Astra Zeneca, outside the submitted work.
Conflict of interest: Dr. Simonneau reports non-financial support from Actelion Pharmaceuticals Ltd, personal fees and non-financial support from Actelion Pharmaceuticals France, during the conduct of the study; grants, personal fees and non-financial support from Actelion Pharmaceuticals Ltd, grants, personal fees and non-financial support from Bayer Healthcare, personal fees and non-financial support from MSD, personal fees and non-financial support from Acceleron, outside the submitted work.
这是一份文章。请点击PDF link above to read it.
- ReceivedSeptember 30, 2019.
- AcceptedApril 4, 2020.
- Copyright ©ERS 2020